The Theme Code "微生物、その培養処理技術" had 1,277 patent application filings in the most recent period (2022-01-01 to 2022-07-31). This is a significantly decreased of -911 filings (-41.6%) over 2,188 they had in the same period of the previous year (2021-01-01 to 2021-07-31).
The company had their highest number of filings in 2016 with 4,559 cases, and their lowest number in 2022 with 1,480 cases.
The mean of the number of filings over the last 5 years (2018 to 2023, 17,708 cases in total) is 2,951, and the median is 3,642. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
Index | Value |
---|---|
Average | 2,951 patents |
Std Dev | 1,618 |
COV | 0.5 |
Year | Cases | YOY |
---|---|---|
2022 year | 1,480 cases | -58.9 % |
2021 year | 3,602 cases | -2.17 % |
2020 year | 3,682 cases | -15.80 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for 微生物、その培養処理技術[4B065] for the period of the last 10 years (2014-01-01 to 2024-03-31). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of 微生物、その培養処理技術, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
The changes in the number of patent filings of 微生物、その培養処理技術 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
Patent landscaping is a visualization of the distribution of patent filings (application focus areas) for each technical keyword. Mountains and islands indicated by heatmap contours represent clusters of patent applications filed, and red areas on the heatmap indicate many patent filings relating to the keyword.
The patent landscape for 微生物、その培養処理技術 gives an intuitive understanding of what patent filings they have made and what technical position is to be established. By selecting filing year checkboxes and filtering, you can track their past filing trends (what technical area they have focused on).
By selecting applicant/patent holder checkboxes and filtering, you can visually grasp the technical areas of the filings for each applicant and the partnerships or alliances formed. Please use it as a guide for patent analysis and IP landscaping.
In addition, by visually representing the patent data in this manner, you can convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
In Patent Integration, you can check the specifics of a patent filing by clicking anywhere on the patent landscape screen. You can also quickly check the position of each applicant for each technical field by cross-referencing with other keywords and patent classifications. You can use it as a guide when considering hypotheses about each company's IP strategy on the IP Landscape. You can also use it for higher-grade intellectual property activities. It has reasonable pricing and a simple user interface that is easy for beginners to handle.
The following is a list of words (characteristic terms) often used in 微生物、その培養処理技術 patent applications. Characteristic terms with a higher importance are used in more patents/patent applications.
This patent analysis report was created for a patent search set of 33,935 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
The patent information of the higher applicant in the technical theme 微生物、その培養処理技術 is shown below. By comparing the number of patents of each company, you can check the research and development status of each company's past and present technical themes and the position of each company in the technical theme.
Comparing the number of applications of each company, 花王株式会社 has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 27 cases, followed by 株式会社カネカ with 17 cases.
Name | Cases |
---|---|
花王株式会社 | 27 cases |
株式会社カネカ | 17 cases |
ザリージェンツオブザユニバーシティオブカリフォルニア | 12 cases |
国立研究開発法人産業技術総合研究所 | 11 cases |
国立大学法人京都大学 | 8 cases |
ジェネンテックインコーポレイテッド | 7 cases |
武田薬品工業株式会社 | 6 cases |
国立研究開発法人理化学研究所 | 5 cases |
味の素株式会社 | 4 cases |
ノバルティスアーゲー | 2 cases |
Comparing the number of applications of each company, ザリージェンツオブザユニバーシティオブカリフォルニア has the highest number of joint applications in the last for the target period (2014 to 2024) with 307 cases, followed by ジェネンテックインコーポレイテッド with 277 cases.
Name | Cases |
---|---|
ザリージェンツオブザユニバーシティオブカリフォルニア | 307 cases |
ジェネンテックインコーポレイテッド | 277 cases |
国立大学法人京都大学 | 267 cases |
ノバルティスアーゲー | 258 cases |
国立研究開発法人産業技術総合研究所 | 202 cases |
花王株式会社 | 182 cases |
国立研究開発法人理化学研究所 | 177 cases |
株式会社カネカ | 164 cases |
味の素株式会社 | 130 cases |
武田薬品工業株式会社 | 98 cases |
国立研究開発法人科学技術振興機構 | 29 cases |
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
The patent information of the higher applicant in the technical theme 微生物、その培養処理技術 is shown below. By comparing the number of patents of each company, you can check the research and development status of each company's past and present technical themes and the position of each company in the technical theme.
among the top coapplicants, 花王株式会社 has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 27 cases, followed by ザリージェンツオブザユニバーシティオブカリフォルニア with 12 cases.
Name | Cases |
---|---|
花王株式会社 | 27 cases |
ザリージェンツオブザユニバーシティオブカリフォルニア | 12 cases |
国立研究開発法人産業技術総合研究所 | 11 cases |
ジェネンテックインコーポレイテッド | 7 cases |
武田薬品工業株式会社 | 6 cases |
味の素株式会社 | 4 cases |
among the top coapplicants, ザリージェンツオブザユニバーシティオブカリフォルニア has the highest number of joint applications in the last for the target period (2014 to 2024) with 307 cases, followed by ジェネンテックインコーポレイテッド with 277 cases.
Name | Cases |
---|---|
ザリージェンツオブザユニバーシティオブカリフォルニア | 307 cases |
ジェネンテックインコーポレイテッド | 277 cases |
国立研究開発法人産業技術総合研究所 | 202 cases |
花王株式会社 | 182 cases |
味の素株式会社 | 130 cases |
武田薬品工業株式会社 | 98 cases |
国立研究開発法人科学技術振興機構 | 29 cases |
Below is a patent map showing the changes in the numbers of JP patent filings by 微生物、その培養処理技術’s top 7 coapplicants over the last 20 years.
微生物、その培養処理技術 filed 202 joint applications with 国立研究開発法人産業技術総合研究所 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 88 cases in total) is 14.7, and the median is 15.0. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The company had their highest number of filings in 2014 with 37 cases, and their lowest number in 2022 with 11 cases.
Index | Value |
---|---|
Average | 14.7 patents |
Std Dev | 8.4 |
COV | 0.6 |
Year | Cases | YOY |
---|---|---|
2022 year | 11 cases | -26.67 % |
2021 year | 15 cases | 0 |
2020 year | 15 cases | -21.05 % |
微生物、その培養処理技術 filed 277 joint applications with ジェネンテックインコーポレイテッド for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 77 cases in total) is 12.8, and the median is 15.0. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The company had their highest number of filings in 2015 with 63 cases, and their lowest number in 2022 with 7 cases.
Index | Value |
---|---|
Average | 12.8 patents |
Std Dev | 7.6 |
COV | 0.6 |
Year | Cases | YOY |
---|---|---|
2022 year | 7 cases | -70.8 % |
2021 year | 24 cases | +71.4 % |
2020 year | 14 cases | -12.50 % |
微生物、その培養処理技術 filed 130 joint applications with 味の素株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 46 cases in total) is 7.7, and the median is 5.0. The coefficient of variation (standard deviation/mean) is 0.8, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The company had their highest number of filings in 2016 with 24 cases, and their lowest number in 2022 with 0 cases.
Index | Value |
---|---|
Average | 7.7 patents |
Std Dev | 6.3 |
COV | 0.8 |
Year | Cases | YOY |
---|---|---|
2022 year | 0 cases | -100 % |
2021 year | 4 cases | -33.3 % |
2020 year | 6 cases | -66.7 % |
微生物、その培養処理技術 filed 98 joint applications with 武田薬品工業株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 64 cases in total) is 10.7, and the median is 9.5. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
The company had their highest number of filings in 2019 with 21 cases, and their lowest number in 2014 with 2 cases.
Index | Value |
---|---|
Average | 10.7 patents |
Std Dev | 7.1 |
COV | 0.7 |
Year | Cases | YOY |
---|---|---|
2022 year | 6 cases | -33.3 % |
2021 year | 9 cases | -10.00 % |
2020 year | 10 cases | -52.4 % |
微生物、その培養処理技術 filed 29 joint applications with 国立研究開発法人科学技術振興機構 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 10 cases in total) is 1.7, and the median is 1.0. The coefficient of variation (standard deviation/mean) is 1.1, and there have been very big fluctuations in the number of filings from year to year.
The company had their highest number of filings in 2015 with 6 cases, and their lowest number in 2022 with 0 cases.
Index | Value |
---|---|
Average | 1.7 patents |
Std Dev | 1.9 |
COV | 1.1 |
Year | Cases | YOY |
---|---|---|
2020 year | 3 cases | +50.0 % |
2019 year | 2 cases | -60.0 % |
2018 year | 5 cases | +25.00 % |
The following shows JP patents held by 微生物、その培養処理技術 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and 微生物、その培養処理技術’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which 微生物、その培養処理技術 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
In the last 3 years (2021-04-01 ~ 2024-03-31), there were 7 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.1 times. The most recently Invalidation Trial patent is 特許6300215 "植物の特性を増強する方法" (Invalidation Trial day 2023-02-03) , next is 特許6896700 "ワクチン組成物" (Invalidation Trial day 2023-01-27) .
- | No. | Title | Invalidation Trial days |
---|---|---|---|
1 | 特許6300215 | 植物の特性を増強する方法 | 2023-02-03 |
2 | 特許6896700 | ワクチン組成物 | 2023-01-27 |
3 | 特許6278598 | 細胞傷害誘導治療剤 | 2022-03-31 |
4 | 特許6773929 | 細胞傷害誘導治療剤 | 2022-03-31 |
5 | 特許6692856 | RNA依存性標的DNA修飾およびRNA依存性転写調節のための方法および組成物 | 2022-02-25 |
6 | 特許6738314 | BCMAおよびCD3に対する結合分子 | 2021-07-02 |
7 | 特許6554730 | ビフィドバクテリウム・ロンガム及び海馬BDNF発現 | 2021-05-17 |
Of the patent applications filed in the last 10 years (2014-04-01 to 2024-03-31), 3 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.3. The most invalidation trial patent is 特許6300215 "植物の特性を増強する方法" (2 times) , and the next most invalidation trial patent is 特許6554730 "ビフィドバクテリウム・ロンガム及び海馬BDNF発現" (1 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6300215 | 植物の特性を増強する方法 | 2 times |
2 | 特許6554730 | ビフィドバクテリウム・ロンガム及び海馬BDNF発現 | 1 times |
3 | 特許6896700 | ワクチン組成物 | 1 times |
In the last 3 years (2021-04-01 ~ 2024-03-31), there were 36 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7316745 "三次元組織体" (Opposition day 2024-01-24) , next is 特許7305630 "N-アセチルノイラミン酸の発酵生産" (Opposition day 2024-01-09) .
- | No. | Title | Opposition days |
---|---|---|---|
1 | 特許7316745 | 三次元組織体 | 2024-01-24 |
2 | 特許7305630 | N-アセチルノイラミン酸の発酵生産 | 2024-01-09 |
3 | 特許7301332 | DNAが編集された真核細胞を製造する方法、および当該方法に用いられるキット | 2024-01-04 |
4 | 特許7300242 | 汚染水処理方法 | 2023-12-27 |
5 | 特許7298844 | 細胞培養物の製造方法 | 2023-12-26 |
6 | 特許7291217 | 足場非依存性細胞およびその使用 | 2023-12-14 |
7 | 特許7270996 | 美容組成物 | 2023-11-10 |
8 | 特許7308329 | GABAを有効成分とするサルコペニア予防または改善剤 | 2023-10-26 |
9 | 特許7262385 | 心筋細胞の成熟 | 2023-10-18 |
10 | 特許7244922 | 化学修飾された一本鎖RNA編集オリゴヌクレオチド | 2023-09-20 |
In the last 3 years (2021-04-01 ~ 2024-03-31), there were 103 patents Protest from third parties. The average number of Protest is 1.3 times. The most recently Protest patent is 特開2023-022363 "細胞保護用剤" (Protest day 2024-03-19) , next is 特開2023-175938 "糖代謝改善用組成物" (Protest day 2024-03-04) .
- | No. | Title | Protest days |
---|---|---|---|
1 | 特開2023-022363 | 細胞保護用剤 | 2024-03-19 |
2 | 特開2023-175938 | 糖代謝改善用組成物 | 2024-03-04 |
3 | 再公表2020/013315 | γδT細胞の製造方法 | 2024-02-19 |
4 | 特開2023-052694 | 悪臭調節化合物の同定方法 | 2024-02-17 |
5 | 特表2023-534047 | オリゴ糖組成物及び使用方法 | 2024-02-07 |
6 | 特表2023-544184 | 接着細胞からのウイルスのバイオリアクター生成 | 2024-02-01 |
7 | 特開2021-090398 | オルニチン高生産酵母、及び酒類又は食品の製造方法 | 2024-01-26 |
8 | 特開2022-097330 | ヤマブシタケ由来のNGF合成促進物質単離のための菌床栽培および製造方法 | 2024-01-24 |
9 | 特開2023-052609 | 細胞培養物の製造方法 | 2024-01-23 |
10 | 特開2021-095350 | 繊維芽細胞増殖促進用組成物、皮膚コラーゲン産生促進用組成物、皮膚ヒアルロン酸産生促進用組成物、皮膚エラスチン産生促進用組成物、及び保湿性の改善用組成物 | 2024-01-17 |
11 | 特開2022-049288 | ビフィズス菌増殖促進効果のある食品素材 | 2024-01-16 |
12 | 特開2021-001160 | スタフィロコッカス・ホミニス(Staphylococcus hominis)の菌量促進のための菌量調整剤 | 2023-12-07 |
13 | 特表2022-548481 | 高剪断可溶化を介してスパイダーシルクタンパク質を単離するための方法 | 2023-11-29 |
14 | 再公表2020/166700 | 血小板溶解物の製造方法、製造システム及びバッグセット | 2023-11-16 |
15 | 特開2022-080035 | ブラウティア属細菌増殖促進用組成物 | 2023-11-15 |
16 | 再公表2018/155436 | 脱窒処理方法および脱窒処理装置 | 2023-10-27 |
17 | 特許7438604 | SARS-COV-2 mRNAドメインワクチン | 2023-10-27 |
18 | 特開2022-073838 | 皮膚における抗光老化剤及びこれを用いた皮膚老化防止・改善剤 | 2023-10-16 |
19 | 特許7471069 | 移植片の活性を高める方法 | 2023-08-09 |
20 | 特許7433217 | RNAウイルスの処理方法 | 2023-08-08 |
Of the patent applications filed in the last 10 years (2014-04-01 to 2024-03-31), 209 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.3. The most protest patent is 特許7128530 "油脂含有排水処理方法、システムおよび装置" (6 times) , and the next most protest patent is 特許7101362 "1,2-ジヒドロキシ-5-(メチルスルフィニル)ペンタン-3-オンの生成能が低い酵母の作出方法" (6 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許7128530 | 油脂含有排水処理方法、システムおよび装置 | 6 times |
2 | 特許7101362 | 1,2-ジヒドロキシ-5-(メチルスルフィニル)ペンタン-3-オンの生成能が低い酵母の作出方法 | 6 times |
3 | 特開2018-199631 | ビフィズス菌含有カプセル製剤 | 4 times |
4 | 再公表2018/155436 | 脱窒処理方法および脱窒処理装置 | 4 times |
5 | 再公表2017/094804 | ドコサヘキサエン酸含有油及びその製造方法 | 4 times |
In the last 3 years (2021-04-01 ~ 2024-03-31), there were 575 patents Inspection from third parties. The average number of Inspection is 1.3 times. The most recently Inspection patent is 特表2021-505168 "操作されたT細胞の組成物を製造するための方法" (Inspection day 2024-03-26) , next is 特開2022-104994 "細胞培養のための細胞外マトリクス組成物ビーズ" (Inspection day 2024-03-26) .
- | No. | Title | Inspection days |
---|---|---|---|
1 | 特表2021-505168 | 操作されたT細胞の組成物を製造するための方法 | 2024-03-26 |
2 | 特開2022-104994 | 細胞培養のための細胞外マトリクス組成物ビーズ | 2024-03-26 |
3 | 特許7433800 | 麹菌の液体組織培養物の製造および利用方法 | 2024-03-25 |
4 | 特表2020-506708 | CO2および他のC1基質の、ビーガン栄養素、肥料、バイオスティミュラント、および土壌炭素隔離の加速のためのシステムへの微生物変換 | 2024-03-19 |
5 | 特表2021-516049 | 組換えT細胞受容体遺伝子を用いて細胞ベースの治療薬を製造するための技法 | 2024-03-19 |
6 | 特開2023-175938 | 糖代謝改善用組成物 | 2024-03-11 |
7 | 特開2022-105066 | がん免疫療法の臨床効果を予測する免疫学的バイオマーカー | 2024-02-27 |
8 | 特開2022-081543 | 抗TREM2抗体及びその使用方法 | 2024-02-27 |
9 | 特表2023-521042 | 操作されたオリゴヌクレオチドを使用する標的化された阻害 | 2024-02-14 |
10 | 特表2022-516496 | キメラ受容体ポリペプチド及びその使用 | 2024-02-14 |
11 | 特表2023-544184 | 接着細胞からのウイルスのバイオリアクター生成 | 2024-02-09 |
12 | 特開2021-003129 | ヒトα−ガラクトシダーゼバリアント | 2024-02-08 |
13 | 特許4977345 | 乾燥羊膜及び羊膜の乾燥処理方法 | 2024-02-07 |
14 | 特表2020-516615 | 上皮バリア機能障害の治療のためのタンパク質 | 2024-02-07 |
15 | 特表2022-504472 | HER2結合四量体ポリペプチド | 2024-02-05 |
16 | 特表2021-500857 | 酵素補充療法用酵素を含む融合タンパク質 | 2024-02-02 |
17 | 特許7304022 | 細胞シート製造装置、および細胞シート | 2024-02-02 |
18 | 特表2020-522489 | 養子細胞療法を用いる処置のための製造物品および方法 | 2024-01-30 |
19 | 特表2021-501566 | CD138に対する抗体分子およびその使用 | 2024-01-25 |
20 | 特開2023-052609 | 細胞培養物の製造方法 | 2024-01-25 |
Of the patent applications filed in the last 10 years (2014-04-01 to 2024-03-31), 1,085 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.3. The most inspection patent is 特許6320473 "アロNKT細胞を用いた免疫療法およびそのためのT細胞抗原受容体(TCR)遺伝子のα鎖領域が均一なVα−Jαに再構成されている細胞および該細胞由来NKT細胞のバンキング" (48 times) , and the next most inspection patent is 特許7433800 "麹菌の液体組織培養物の製造および利用方法" (13 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6320473 | アロNKT細胞を用いた免疫療法およびそのためのT細胞抗原受容体(TCR)遺伝子のα鎖領域が均一なVα−Jαに再構成されている細胞および該細胞由来NKT細胞のバンキング | 48 times |
2 | 特許7433800 | 麹菌の液体組織培養物の製造および利用方法 | 13 times |
3 | 特開2015-107131 | ADAM6マウス | 12 times |
4 | 再公表2019/172112 | 細胞凍結保存用溶液およびその利用 | 10 times |
5 | 再公表2017/094804 | ドコサヘキサエン酸含有油及びその製造方法 | 9 times |
Of the patent applications filed in the last 10 years (2014-04-01 to 2024-03-31), 4,551 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.1. The most cited patent is 特許6196343 "免疫グロブリンに特異的に結合するタンパク質および免疫グロブリン結合性アフィニティーリガンド" (36 times) , and the next most cited patent is 特許6395765 "配列操作のための改善された系、方法および酵素組成物のエンジニアリングおよび最適化" (33 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6196343 | 免疫グロブリンに特異的に結合するタンパク質および免疫グロブリン結合性アフィニティーリガンド | 36 times |
2 | 特許6395765 | 配列操作のための改善された系、方法および酵素組成物のエンジニアリングおよび最適化 | 33 times |
3 | 特許6738729 | 分裂終了細胞の疾患および障害をターゲティングおよびモデリングするための系、方法および組成物の送達、エンジニアリングおよび最適化 | 28 times |
4 | 特許6621738 | RNA誘導性転写制御 | 23 times |
5 | 特許7065564 | CAS9ニッカーゼ活性を用いて正確なDNA切断をもたらすための方法 | 22 times |
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International